Methadone
Methadone is a long-lasting, affordable medication that alleviates withdrawal symptoms and prevents cravings.
Brixadi is an extended-release form of buprenorphine that is injected once a month to treat individuals suffering from moderate to severe opioid use disorder (OUD). After receiving FDA approval in 2023, Brixadi has become an effective alternative to other single-dose buprenorphine treatments.
Like Suboxone and Sublocade, Brixadi reduces withdrawal symptoms, the likelihood of relapse, and the cravings associated with OUD. With a wide range of dosing options available, Brixadi can be tailored to meet each patient’s unique needs.
Brixadi can be administered weekly or monthly, allowing patients to adjust their treatment to suit their unique needs and taper the medication as treatment progresses.
For patients who may struggle with higher doses of injectable buprenorphine, Brixadi offers various strengths to help patients of all tolerance levels receive treatment.
Brixadi injections are effective from multiple recommended injection sites, whether through the buttock, thigh, abdomen, or upper arm.
Brixadi is designed to minimize opioid cravings and withdrawal symptoms to help patients stay in treatment and avoid relapse.
Need help getting to a CMS clinic? Community Medical Services can help you find cost-effective (in some cases complimentary to start) transportation services near you. Our goal is to get you to us as quickly as possible, today, to begin your road to recovery.
8444 N. 90th Street, Suite 100
Scottsdale, AZ 85258
